IFYBER LLC

Medtech · Private

Nitric oxide-releasing biomaterial wound dressing with sustained NO-delivery system

ifyber.com →
Grants
$1.2M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$6.3M
12 awards · Defense, Health and Human S
#99 of 4531 in medtech
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Defense · SBIR Phase I$99,999
Federal contractDepartment of Defense · Research And Development In The Physical, Engineer$69,999
Federal contractDepartment of Defense · SBIR Phase I (A013-160-0457)$69,900
Federal contractDepartment of Defense · Darpa SBIR Phase I Entitled "lab-on-a-bubble: A Powerful, Low-cost, Point-of-care, Diagnostic Platform Technology"$100,000
Federal contractDepartment of Defense · #mpeg-pdha Hemostatic Agent$11,000
Federal contractDepartment of Health and Human Services · Igf::ot::igf Special Studies/analysis- Scientific Data$197,095
Federal contractDepartment of Defense · #mpeg-pdha Hemostatic Agent,$8,000
Federal grantDepartment of Health and Human Services · Phase I · A Nitric Oxide Polymer Platform for the Prevention and Treatment of Infected Wounds$255,827
Federal grantDepartment of Health and Human Services · Phase I · A Nitric Oxide Polymer Platform for the Prevention and Treatment of Infected Wounds$255,827
Federal grantDepartment of Health and Human Services · Phase I · Peptide-based wound dressing for prevention and management of infected wounds$215,957
Federal grantDepartment of Health and Human Services · Phase I · Peptide based wound dressing for prevention and management of infected wounds$215,957
Federal contractDepartment of Defense · Igf::ct::igf SBIR Phase I Award Compressive Habiliment Integrated Technology For Continuous Health Assessment Tasks$149,837
Federal contract· 1 of 2 same dayDepartment of Health and Human Services · SBIR Phase I Igf::ot::ogf$149,983
Federal contract· 2 of 2 same dayDepartment of Defense · Dha 2017.1 SBIR Phase II Medical R&d Contract For Proposal H2- 0331 For Project Titled,"rapid Field Testing Of Field Water Samples For Total Coliform And E. Coli Using Isothermal Amplification And Unique Micron-sized Particles For Cell Capture And Concentration"$1,999,090
Federal grantDepartment of Health and Human Services · Phase I · Development of wound care formulations for PVP/NO: A novel nitric oxide releasing platform with potent antimicrobial and anti-biofilm properties$299,356
Federal contractDepartment of Defense · Research Medical Research And Development Dha SBIR Direct To Phase II Proposal No. H2D-0027 Titled Standard-issue Antimicrobial Combat Burn Gauze.$2,195,570
Federal contractDepartment of Defense · Defense Health Agency Sequential Phase II Sir Topic DHA201-D001 To Ifyber Llc.$1,298,777
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
96DIAGNOSTICS FOR THE REAL WORLD LIMITED$6.5M—
97CVD EQUIPMENT CORPORATION$6.5M—
98AccuVein Inc.$6.4M$48M
99IFYBER LLC$6.3M—
100Axion Biosystems, Inc.$6.3M$21M
101Whoop, Inc.$6.3M$177M
102Electrical Geodesics, Inc.$6.3M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Method Of Detecting An Analyte Using Coated Hollow Microspheres And Method Of Producing Sameapplication
  • Method Of Detecting An Analyte Using Coated Hollow Microspheres And Method Of Producing Sameapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.